Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Language English Country Great Britain, England Media electronic-print
Document type Editorial
PubMed
30655449
DOI
10.1183/13993003.02077-2018
PII: 53/1/1802077
Knihovny.cz E-resources
- MeSH
- Antitubercular Agents therapeutic use MeSH
- European Union MeSH
- Latent Tuberculosis drug therapy prevention & control MeSH
- Humans MeSH
- Program Development methods MeSH
- Practice Guidelines as Topic * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Editorial MeSH
- Names of Substances
- Antitubercular Agents MeSH
Dept of Infectious Disease Epidemiology London School of Hygiene London UK
Dept of Infectious Disease Epidemiology Robert Koch Institute Berlin Germany
Dept of Infectious Diseases Karolinska Institute Stockholm Sweden
Dept of Public Health Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands
Division of Infectious Diseases Karolinska University Hospital Stockholm Sweden
European Centre for Disease Prevention and Control Stockholm Sweden
Istituti Clinici Scientifici Maugeri IRCCS Tradate Italy
KNCV Tuberculosis Foundation The Hague The Netherlands
National Institute for Public Health and the Environment Bilthoven The Netherlands
Norwegian Institute of Public Health Oslo Norway
Pallas Health Research and Consultancy Rotterdam The Netherlands
Public Health England London UK
TB Modelling Group TB Centre London School of Hygiene and Tropical Medicine London UK
References provided by Crossref.org
